Special Issue "Novel Coronavirus (SARS-CoV-2) Outbreak: Epidemiology, Research and Implications for Public Health"
Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 88535
Interests: biostatistics; clinical epidemiology and public health; air, surfaces and personnel microbial monitoring in high risk environments (surgery rooms and intensive care units); epidemiology and prevention of infectious diseases
Interests: public health; infectious diseases; tropical medicine, refugees and migrants health, vaccine-preventable diseases; health diplomacy; health policies
At the end of December 2019, Chinese authorities reported the spread of a novel coronavirus (named 2019-nCoV before, newly defined as SARS-CoV-2) responsible for cases of acute respiratory syndrome in the Wuhan municipality. In a few weeks, the spread of this new strain of coronavirus rapidly evolved, affecting other parts of China and determining cases outside the country. Further global diffusion can be not excluded, and it is expected that international exportation of cases may occur worldwide. To reduce the risk of a possible epidemic, the World Health Organization has declared the current outbreak a global public health emergency and invites all countries to be prepared for containment, including through active surveillance and case management.
Unfortunately, to date there is still a limited knowledge about the characteristics of the virus, how it spreads between people, how severe are the resulting infections, and how to treat them. To answer these questions, the scientific international community is committed to rapidly covering these gaps and sharing emerging information on this topic. In particular, healthcare professionals are called to put in place strong measures to detect disease early, isolate and treat cases, trace contacts, and prevent and reduce the spread of the infection.
According to the previously reported considerations, in this Special Issue we particularly welcome articles and commentaries providing new insights into general epidemiology of this novel virus, disease prevention and control strategies, risk management and communication, evaluation of the impact of public health interventions, and innovative researches for developing necessary pharmaceutical and non-pharmaceutical treatments.
Dr. Emanuele Amodio
Dr. Palmira Immordino
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Novel coronavirus
- Public health
- Disease prevention
- Control strategies
- Risk management and communication
- Innovative researches